Press Releases

Date	Title	Company
10-Nov-2022	Stoke Therapeutics to Host Webinar and Conference Call to Present Interim Data from the Phase 1/2a Studies of STK-001 in Children and Adolescents with Dravet Syndrome	Businesswire
10-Nov-2022	Last-Mile Delivery Robot Global Market Report 2022: Growth of E-Commerce and Q-Commerce Industries Drive Sector - ResearchAndMarkets.com	Businesswire
10-Nov-2022	CRO Industry Leader Davide Molho Joins Summit Partners as Executive-in-Residence	Businesswire
10-Nov-2022	Seagen Appoints Sandra M. Swain, M.D., to Board of Directors	Businesswire
10-Nov-2022	Klick Health forma equipe e escritórios globais	Businesswire
10-Nov-2022	Klick Health crea equipos y oficinas de liderazgo global	Businesswire
10-Nov-2022	Silence Therapeutics Reports Third Quarter 2022 Results	Businesswire
10-Nov-2022	Aldeyra Therapeutics Reports Third-Quarter 2022 Financial Results and Recent Corporate Highlights	Businesswire
10-Nov-2022	Aura Biosciences Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights	Businesswire
10-Nov-2022	US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations	Businesswire
10-Nov-2022	Seagen Names David R. Epstein as Chief Executive Officer and Director	Businesswire
10-Nov-2022	Parthenon Therapeutics and ImaginAb Announce License and Supply Agreement to Advance New Class of Anti-Cancer Therapies’ Clinical Development Program	Businesswire
10-Nov-2022	BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers	Businesswire
10-Nov-2022	Aura Announces Global Phase 3 Trial Design with Suprachoroidal Route of Administration Based on Positive Phase 2 Interim Data of Belzupacap Sarotalocan in Early-Stage Choroidal Melanoma	Businesswire
10-Nov-2022	2022 Monthly Neurotech Business Report: Company Management, Customer Base, Core Technology, Competitive Position, Financial History and Future Outlook - ResearchAndMarkets.com	Businesswire
10-Nov-2022	ROME Therapeutics Demonstrates Efficacy of its Novel LINE-1 Reverse Transcriptase Inhibitor in Translational Models of Autoimmune Disease	Businesswire
10-Nov-2022	The Worldwide Bromelain Industry is Projected to Reach $45 Million by 2030 at a 7.1% CAGR - ResearchAndMarkets.com	Businesswire
10-Nov-2022	Heidelberg Pharma and Partner Magenta to Present Initial Clinical Data on their Antibody Drug Conjugates at the ASH Annual Meeting 2022	Heidelberg Pharma AG
10-Nov-2022	SOTIO Presents Preclinical Data from BOXR CAR-T Program and Trial Design of Phase 2 AURELIO-04 Study at SITC Annual Meeting	B3C newswire
10-Nov-2022	Pharmacovigilance Global Market Report 2022: Rising Cases of Adverse Drug Reactions Fueling Growth - ResearchAndMarkets.com	Businesswire